Financial statements Gemini Pharm

Balance sheet of Gemini Pharm

Company age:
Age:
10 y. 19 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of GEMINI PHARM

Year
2020
2021
2022
2023
Total assets 43 379 873,52 49 283 164,72 61 929 683,24 74 842 205,02
A. Fixed assets 2 689 307,85 2 367 802,79 2 203 433,66 12 314 834,71
B. Current assets 40 690 565,67 46 915 361,93 59 726 249,58 62 527 370,31
C. Share capital contributions (basic funds) - - - -
D. Own shares (stocks) - - - -
Total liabilities 43 379 873,52 49 283 164,72 61 929 683,24 74 842 205,02
A. Equity -12 223 386,60 -11 595 213,90 -12 095 461,95 -12 547 088,13
B. Liabilities and provisions for liabilities 55 603 260,12 60 878 378,62 74 025 145,19 87 389 293,15
I. Long-term liabilities 35 053 952,00 0,00 - 29 334 698,54
II. Short-term liabilities 18 693 558,83 58 726 613,32 71 723 822,73 55 615 358,14
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.